International Biotechnology Trust PLCInternational Biotechnology Trust PLC - ESG Rating & Company Profile powered by AI

Industry Group:UK Investment Trusts

Alternative corporations in the scoring industry group for International Biotechnology Trust PLC are displayedin the table. This dashboard contains a questions and answers table on International Biotechnology Trust PLC. This Sustainability assessment for International Biotechnology Trust PLC indicates the company's transparency towards the United Nations SDGs.

International Biotechnology Trust PLC in the UK Investment Trusts industry gained a UN SDG ESG Transparency Score of 5.3; made up of an environmental score of 3.4, social score of 5.7 and governance score of 6.7.

SDG Transparency Score for International Biotechnology Trust PLC 
Low
0 - 3

5.3

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for International Biotechnology Trust PLC 
3.4

Environmental

5.7

Social

6.7

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Perpetual Ltd
8.3
High
2Baillie Gifford Japan Trust PLC
8.0
High
110CD Equity Fund I Pvt
5.5
High
110Schroder Income Growth Fund PLC
5.5
High
113International Biotechnology Trust PLC
5.3
High
113Chelverton UK Dividend Trust PLC
5.3
High
113MFF Capital Investments Ltd
5.3
High
.........
260Puma VCT 10 PLC
0.0
Low
260Sherborne Investors (Guernsey) A Ltd
0.0
Low
.........
View the full peer group of 361 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does International Biotechnology Trust PLC have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose current and historical energy intensity?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC report the average age of the workforce?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose cybersecurity risks?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC offer flexible work?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC conduct supply chain audits?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does International Biotechnology Trust PLC conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose water use targets?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did International Biotechnology Trust PLC have a product recall in the last two years?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose incidents of discrimination?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has International Biotechnology Trust PLC issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose parental leave metrics?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is International Biotechnology Trust PLC involved in embryonic stem cell research?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose its waste policy?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC report according to TCFD requirements?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose energy use targets?

LockedSign up for free to unlock

Does International Biotechnology Trust PLC disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does International Biotechnology Trust PLC have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for International Biotechnology Trust PLC
These potential risks are based on the size, segment and geographies of the company.

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of the

Sorry!

Failed to process!